Association between depression, anxiety, chronic pain, or opioid use and tumor necrosis factor inhibitor persistence in inflammatory arthritis.
Guy KatzPhilip S HelliwellJoshua F BakerMichael D GeorgePublished in: Clinical rheumatology (2022)
Depression, anxiety, chronic pain, and opioid use are common in inflammatory arthritis and associated with earlier TNFi discontinuation. Recognizing and managing these risk factors may improve treatment persistence, patient outcomes, and cost of care. Key Points • Depression, anxiety, chronic pain, and opioid use are common in patients with inflammatory arthritis. • In patients initiating treatment with a TNF-inhibitor, depression, anxiety, chronic pain, or recent opioid use are associated with sooner discontinuation of TNFi therapy. • Patients with multiple of these risk factors are even more likely to discontinue therapy sooner.
Keyphrases
- chronic pain
- sleep quality
- rheumatoid arthritis
- risk factors
- pain management
- depressive symptoms
- oxidative stress
- end stage renal disease
- newly diagnosed
- chronic kidney disease
- ejection fraction
- physical activity
- stem cells
- prognostic factors
- replacement therapy
- patient reported
- health insurance
- chemotherapy induced